Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

H9 Priming Study in Healthy Adults

Phase 2

Completed

Conditions: Influenza

Interventions: Biological: Subvirion inactivated influenza A/H9N2 (G9 variant) vaccine

First Posted Date: 2008-02-18

Last Posted Date: 2011-07-22

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 121

Registration Number: NCT00617331

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

Phase 1

Completed

Conditions: Atopic Dermatitis

Interventions: Biological: KLH carrier-protein

First Posted Date: 2008-02-13

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 25

Registration Number: NCT00614731

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Phase 1

Withdrawn

Conditions: HIV Infections

Interventions: Biological: DermaVir patch
Biological: Placebo patch

First Posted Date: 2008-02-13

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00614640

Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)

Completed

Conditions: Kidney Transplantation

First Posted Date: 2008-02-11

Last Posted Date: 2015-05-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 588

Registration Number: NCT00611702

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Mt. Sinai School of Medicine, New York, New York, United States
🇦🇺
Westmead Hospital, Sydney, New South Wales, Australia

and more 2 locations

Live Kidney Donor Study

Completed

Conditions: Kidney Transplantation
End Stage Renal Disease

First Posted Date: 2008-02-06

Last Posted Date: 2017-03-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 8951

Registration Number: NCT00608283

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Dyskinesia, Heterotaxy and Congenital Heart Disease

Completed

Conditions: Kartagener Syndrome
Congenital Heart Defects
Situs Inversus
Ciliary Dyskinesia, Primary

First Posted Date: 2008-02-06

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 3

Registration Number: NCT00608556

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
Childrens National Medical Center, Washington, D.C., District of Columbia, United States

Ebola and Marburg Virus Vaccines

Phase 1

Completed

Conditions: Marburgvirus
Ebolavirus
Ebola Vaccines
Marburg Virus Disease
Ebola Virus Disease

First Posted Date: 2008-01-31

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 20

Registration Number: NCT00605514

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Phase 2

Completed

Conditions: HIV Infections
Sexually Transmitted Diseases

Interventions: Biological: Quadrivalent HPV vaccine

First Posted Date: 2008-01-30

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 319

Registration Number: NCT00604175

Locations: 🇺🇸
Pediatric Perinatal HIV Clinical Trials Unit CRS, Miami, Florida, United States
🇺🇸
The Ponce de Leon Center CRS, Atlanta, Georgia, United States
🇺🇸
Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program, Chicago, Illinois, United States

and more 58 locations

Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

Phase 1

Completed

Conditions: HIV Infections

Interventions: Drug: Tenofovir gel
Drug: Tenofovir gel placebo

First Posted Date: 2008-01-15

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 30

Registration Number: NCT00594373

Locations: 🇺🇸
Albert Einstein College of Medicine - East Campus GCRC (Herold) Non-Network CRS, Bronx, New York, United States

MRI to Measure Liver Fat Content

Not Applicable

Completed

Conditions: Hepatitis
Fatty Liver

First Posted Date: 2008-01-15

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 53

Registration Number: NCT00594412

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy